Arkansas legislation · 95th General Assembly (2025 Regular)
Arkansas SB589: TO CREATE THE 340B PROGRAM TRANSPARENCY ACT; AND TO AMEND THE LAW CONCERNING TRANSPARENCY AND ACCOUNTABILITY FOR CERTAIN 340B-COVERED ENTITIES
Status: Failed, May 5, 2025
What the bill says
An act to be entitled an act to create the 340b program transparency act; to require transparency from certain 340b-covered entities concerning the use of 340b program savings; to require certain 340b-covered entities to annually report the utilization and distribution of 340b program savings to ensure accountability and transparency; and for other purposes. subtitle to create the 340b program transparency act; and to amend the law concerning transparency and accountability for certain 340b-covered entities.
From the introduced text:
An Act To Be Entitled AN ACT TO CREATE THE 340B PROGRAM TRANSPARENCY ACT; TO REQUIRE TRANSPARENCY FROM CERTAIN 340B-COVERED ENTITIES CONCERNING THE USE OF 340B PROGRAM SAVINGS; TO REQUIRE CERTAIN 340B-COVERED ENTITIES TO ANNUALLY REPORT THE UTILIZATION AND DISTRIBUTION OF 340B PROGRAM SAVINGS TO ENSURE ACCOUNTABILITY AND TRANSPARENCY; AND FOR OTHER PURPOSES. Subtitle TO CREATE THE 340B PROGRAM TRANSPARENCY ACT; AND TO AMEND THE LAW CONCERNING TRANSPARENCY AND ACCOUNTABILITY FOR CERTAIN 340B-COVERED ENTITIES. BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF ARKANSAS: SECTION 1. Arkansas Code Title 20, Chapter 6, is amended to add an additional subchapter to read as follows: Subchapter 5 -- 340B Program Transparency Act 20-6-501. Title. This subchapter shall be known and may be cited as the "340B Program Transparency Act". 20-6-502. Definitions. As used in this subchapter: (1) "340B program" means the federal drug discount program *JMB451* 03/31/2025 1:46:16 PM JMB451 SB589 established under Section 340B of the Public Health Service Act, 42 U.S.C. § 256b, as it existed on January 1, 2025, that requires a drug manufacturer to provide discounted outpatient medications to a covered entity that serves a significant number of low-income and uninsured patients; (2) "340B savings" means the difference between the actual price paid by a covered entity or its contract pharmacy under the 340B program for …